144 related articles for article (PubMed ID: 31274696)
1. Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis.
Shinfuku M; Kishimoto T; Uchida H; Suzuki T; Mimura M; Kikuchi T
Int Clin Psychopharmacol; 2019 Sep; 34(5):211-221. PubMed ID: 31274696
[TBL] [Abstract][Full Text] [Related]
2. Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: Systematic review and meta-analysis.
Gale C; Glue P; Guaiana G; Coverdale J; McMurdo M; Wilkinson S
J Psychopharmacol; 2019 May; 33(5):543-547. PubMed ID: 30676225
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.
Offidani E; Guidi J; Tomba E; Fava GA
Psychother Psychosom; 2013; 82(6):355-62. PubMed ID: 24061211
[TBL] [Abstract][Full Text] [Related]
4. An open-label trial of risperidone augmentation for refractory anxiety disorders.
Simon NM; Hoge EA; Fischmann D; Worthington JJ; Christian KM; Kinrys G; Pollack MH
J Clin Psychiatry; 2006 Mar; 67(3):381-5. PubMed ID: 16649823
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.
Li X; Zhu L; Zhou C; Liu J; Du H; Wang C; Fang S
PLoS One; 2018; 13(3):e0194501. PubMed ID: 29558528
[TBL] [Abstract][Full Text] [Related]
6. The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials.
Rossano F; Caiazza C; Zotti N; Viacava L; Irano A; Solini N; Pistone L; Pezone R; Cilmi F; Ricci C; De Prisco M; Iasevoli F; Kishi T; Solmi M; de Bartolomeis A; Fornaro M
Eur Neuropsychopharmacol; 2023 Nov; 76():23-51. PubMed ID: 37544075
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder.
Beyer C; Currin CB; Williams T; Stein DJ
Compr Psychiatry; 2024 Jul; 132():152479. PubMed ID: 38564872
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety.
Rickels K; Moeller HJ
World J Biol Psychiatry; 2019 Sep; 20(7):514-518. PubMed ID: 30252578
[No Abstract] [Full Text] [Related]
9. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
10. A major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disorders.
Berney P; Halperin D; Tango R; Daeniker-Dayer I; Schulz P
Psychopharmacol Bull; 2008; 41(3):39-47. PubMed ID: 18779775
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials.
Martin JL; Sainz-Pardo M; Furukawa TA; Martín-Sánchez E; Seoane T; Galán C
J Psychopharmacol; 2007 Sep; 21(7):774-82. PubMed ID: 17881433
[TBL] [Abstract][Full Text] [Related]
12. Perceptions, clinical characteristics, and other factors associated with prolonged and high daily dose of benzodiazepine use among patients with anxiety or depressive disorders.
Chen YT; Liu CY; Chang CM; Lai YM; Wang BH; Yang TY; Hsu SC
J Affect Disord; 2020 Jun; 271():215-223. PubMed ID: 32479319
[TBL] [Abstract][Full Text] [Related]
13. A fixed-dose study of adinazolam-SR tablets in generalized anxiety disorder.
Wilcox CS; Ryan PJ; Morrissey JL; Cohn JB; DeFrancisco DF; Linden RD; Heiser JF
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):979-93. PubMed ID: 7824763
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyzine for generalised anxiety disorder.
Guaiana G; Barbui C; Cipriani A
Cochrane Database Syst Rev; 2010 Dec; (12):CD006815. PubMed ID: 21154375
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia.
Montgomery SA; Herman BK; Schweizer E; Mandel FS
Int Clin Psychopharmacol; 2009 Jul; 24(4):214-22. PubMed ID: 19542983
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
17. Passiflora for anxiety disorder.
Miyasaka LS; Atallah AN; Soares BG
Cochrane Database Syst Rev; 2007 Jan; (1):CD004518. PubMed ID: 17253512
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
19. Prescription Benzodiazepine Use Among Older Adults: A Critical Review.
Gerlach LB; Wiechers IR; Maust DT
Harv Rev Psychiatry; 2018; 26(5):264-273. PubMed ID: 30188338
[TBL] [Abstract][Full Text] [Related]
20. Should benzodiazepines be replaced by antidepressants in the treatment of anxiety disorders? Fact or fiction?
Rickels K
Psychother Psychosom; 2013; 82(6):351-2. PubMed ID: 24061092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
